FDA

Airiver Medical Granted FDA’s Breakthrough Device Designation for Pulmonary Drug Coated Balloon to Treat Central Airway Stenosis; First Patient Treated in Clinical Trial

Designation may provide U.S. patients faster access to groundbreaking technology [...]

By |2026-03-04T16:04:11+00:00March 4, 2026|3rd Party Medical Device Industry News|Comments Off on Airiver Medical Granted FDA’s Breakthrough Device Designation for Pulmonary Drug Coated Balloon to Treat Central Airway Stenosis; First Patient Treated in Clinical Trial

FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen DeficiencyFDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency

The 2-gram single-dose bottle joins the existing 1-gram version, giving [...]

By |2026-01-07T16:53:24+00:00January 7, 2026|3rd Party Medical Device Industry News|Comments Off on FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen DeficiencyFDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency
Go to Top